Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Tuesday, December 6, 2022 · 605,035,013 Articles · 3+ Million Readers

Vaccines Market Size to Grow at a CAGR of 6.6% to Reach USD 72,129.61 Million by 2031

Vaccines market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.

PORTLAND, OREGON, UNITED STATES, October 3, 2022 /EINPresswire.com/ -- Vaccines industry was estimated at $38.06 billion in 2021, and is anticipated to hit $72.12 billion by 2031, registering a CAGR of 6.6% from 2022 to 2031. Surge in investment toward development of new vaccines drives the growth of the global vaccines market. Several efforts undertaken by different organizations across the world have supplemented the growth even more. Moreover, increase in administration of vaccines has created a number of lucrative opportunities in the industry.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

• Pfizer
• Johnson & Johnson
• AstraZeneca plc
• Sanofi Aventis
• Merck & Co., Inc.
• Serum Institute of India Pvt. Ltd.
• Emergent BioSolutions Inc.
• CSL Limited
• Novavax, Inc.
• GlaxoSmithKline plc

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/258

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

• The outbreak of the pandemic impacted the global vaccines market negatively, as the focus of the market shifted from traditional vaccines to only Covid-19 vaccines.
• Along with this, the pandemic had affected the supply chain resulting in lower demand and higher inventory adjustments.
• Major vaccine manufacturers have focused majorly on Covid-19 vaccine manufacturing and denied working on some of the previous vaccines in the pipeline, as the R&D investments were high for Covid-19 inoculations.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/258

Based on technology, the recombinant & conjugate segment accounted for more than two-fifths of the global vaccines market share in 2021, and is anticipated to rule the roost by 2031. The same segment would also cite the fastest CAGR of 7.5% throughout the forecast period. Increase in number of regulatory clearances and significant role of recombinant vaccines like glycoconjugates vaccine in the market propel the growth of the segment.

Based on technology, the recombinant & conjugate segment accounted for more than two-fifths of the global vaccines market share in 2021, and is anticipated to rule the roost by 2031. The same segment would also cite the fastest CAGR of 7.5% throughout the forecast period. Increase in number of regulatory clearances and significant role of recombinant vaccines like glycoconjugates vaccine in the market propel the growth of the segment.

Based on region, North America held the major share in 2021, generating more than two-fifths of the global vaccines market, due to the expanding construction sector, due to investments made by several key players for various R&D activities as well as launch of new products in the United States. At the same time, the market across Asia-Pacific would grow at the fastest CAGR of 8.1% by 2031. This is owing to high burden of diseases, increase in affordability, and improvements in healthcare access in developing countries such as India and China.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Neuroprosthetics Market

Intraoperative Imaging Market

𝐀𝐥𝐬𝐨 𝐑𝐞𝐚𝐝 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐁𝐥𝐨𝐠:

Singapore Atrial Fibrillation Market Size, Key Market -- https://singaporehealthcarenews.blogspot.com/2022/10/singapore-atrial-fibrillation-market.html

Singapore Biopharmaceuticals Market -- https://singaporehealthcarenews.blogspot.com/2022/10/biopharmaceuticals-market-revenue.html

𝐀𝐕𝐄𝐍𝐔𝐄- 𝐀 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐁𝐚𝐬𝐞𝐝 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥) 𝐎𝐟𝐟𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

𝐆𝐞𝐭 𝐚𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐢𝐛𝐫𝐚𝐫𝐲 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐚𝐭 𝐚𝐧𝐲 𝐭𝐢𝐦𝐞 𝐟𝐫𝐨𝐦 𝐚𝐧𝐲 𝐝𝐞𝐯𝐢𝐜𝐞 𝐚𝐧𝐝 𝐚𝐧𝐲𝐰𝐡𝐞𝐫𝐞. 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬, 𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.alliedmarketresearch.com/library-access

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release